You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
25 November 2025 - Danish pharmaceutical company Novo Nordisk A/S (CPH:NOVO-B) (NYSE:NVO) on Tuesday reported positive phase 2 results for amycretin in people with type 2 diabetes, showing statistically significant weight loss of up to 14.5% and HbA1...
25 November 2025 - Swedish biotechnology company Active Biotech AB (STO:ACTI) announced on Tuesday that the US Patent and Trademark Office has confirmed it will grant a patent for a pharmaceutical formulation of tasquinimod on 2 December 2025, under ...
25 November 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Tuesday that the European Commission has approved Dupixent (dupilumab) for adults and adolescents aged 12 and older with moderate-to-severe chroni...
25 November 2025 - Blacksmith Medicines Inc, a biopharma company focused on discovering and developing therapeutics targeting metalloenzymes, announced on Monday that the European Patent Office has issued a Notice of Intention to Grant for European A...
24 November 2025 - Medical technology company LivaNova PLC (Nasdaq: LIVN) announced that the U.S. Centers for Medicare & Medicaid Services (CMS) will assign VNS Therapy for drug-resistant epilepsy (DRE) new patient implants to New Technology Ambu...
24 November 2025 - AstraZeneca PLC (LSE: AZN) (STO: AZN) (Nasdaq: AZN) declared on Monday that it will invest USD2bn to expand its manufacturing footprint in Maryland, adding capacity at its Frederick biologics plant and building a new clinical manuf...